References
Brody B, Dubler N, Blustein J, et al. Bioethics consultation in the private sector. Hastings Center Report. 2002; 32 (3): 14–20.
Brunk C, Haworth L, Lee B. Value assumptions in risk assessment: A case study of the Alachlor controversy. Waterloo: Wilfred Laurier University Press; 1991.
Douglas M, Wildavsky A. Risk and culture: An essay on the selection of technological and environmental dangers. Berkeley: University of California Press; 1982.
Dawes, RM. Rational choice in an uncertain world. San Diego: Harcourt Brace Jovanovich; 1988.
MacDonald C. Higher standards for privately funded health research. Canadian Bioethics Society Newsletter, 2004; 9 (1).
Elliott C. Not-so-public relations: How the drug industry is branding itself with bioethics. Slate, December 15, 2003; [On-line] Available at: http://slate.msn.com/id/2092442/..
MacDonald C. Business ethics 101 for the biotech industry. Biodrugs. 2004; 18 (2) (in press).
MacDonald C. Will the ‘secular priests’ of bioethics work among the sinners? American Journal of Bioethics. 2003; 3 (2). [On-line] Available at: http://www.bioethics.net/journal/j_articles.php?aid=90. (Last visited 11/13/04).
Maher K. Career journal: Wanted: Ethical employer – Job hunters, seeking to avoid an Enron or an Andersen, find it isn’t always easy. Wall Street Journal (Eastern edition), New York, N.Y.: July 9, 2002;B1.
Park P, Grimwade A, Cohen H, et al. The pleasures and perils of scientists in industry: Scientists rank practicing ethical standards as the most important characteristic. The Scientist. June 16, 2003; 17:12
Clark MM. Corporate ethics programs make a difference, but not the only difference. HR Magazine, July 2003; 48 (7): 36.
Schmitt RB. Companies add ethics training: Will it work? Wall Street Journal (Eastern edition), November 4, 2002; B1.
Orr RD, Morton KR, deLeon DM, et al. Evaluation of an ethics consultation service: Patient and family perspective. American Journal of Medicine, 1996; 101: 135–141.
Tulsky JA, Fox E. Evaluating ethics consultation: Framing the questions. The Journal of Clinical Ethics, 1996; 7 (2): 109–115.
Society for Health and Human Values - Society for Bioethics Consultation Task Force on Standards for Bioethics Consultation (SHHV/SBC). Core competencies for health care ethics consultation: C. MacDonald The report of the American Society for Bioethics and Humanities. Lake View, Illinois: American Society for Bioethics and Humanities; 1998.
Aulisio MP. Ethics consultation: Is it enough to mean well? HEC Forum, 1999;11 (3): 208–217.
Elliott C. Pharma buys a conscience. The American Prospect, September 24–October 8, 2001; 12(17). [On-line] Available at: http://www.prospect.org/print-friendly/print/V12/17/elliott-c.html. (Last visited 8/30/02).
Callahan D. Doing well and doing good. Hastings Center Report, 2001. 31(2): 19–21.
MacDonald C, McDonald M, Norman W. Charitable conflicts of interest. Journal of Business Ethics, August 2002; 39(1–2): 67–74.
Saletan W. The Ethicist’s new clothes, Slate. August 17, 2001. [Online] Available at: http://slate.msn.com/?id=113959&&. (last visited 11/13/04).
Stolberg SG. Bioethicists fall under familiar scrutiny. New York Times, August 2, 2001.
Wanna buy a bioethicist? Christianity Today, October 1, 2001; 45(12): 32.
Cummins D. The professional status of bioethics consultation. Theoretical Medicine and Bioethics, 2002; 23 (1): 19–43.
Rights and permissions
About this article
Cite this article
Macdonald, C. Corporate Ethics in the Life Sciences: Can Bioethics Help? Should it?. HEC Forum 17, 122–134 (2005). https://doi.org/10.1007/s10730-005-7297-2
Issue Date:
DOI: https://doi.org/10.1007/s10730-005-7297-2